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Abstract 
Recent reports indicate that vacuolar-type proton ATPases from chicken osteoclasts (Chatterjee et al. (1992) Proc. Natl. Acad. Sci. 
USA 89, 6257-6261), yeast vacuoles and chromaffin granules (Beltran and Nelson (1992) Acta Physiol. Stand. Suppl. 607, 41-47) can 
be inhibited by vanadate, albeit at a concentration much higher than that required to inhibit P-type ATPases. We have characterized the 
mechanism by which vanadate inhibits vacuolar-type ATPase-mediated proton transport by chicken kidney microsomes. The initial rate of 
proton transport is somewhat less sensitive to vanadate than the total acidification, with IC,, values of 1.58 mM and 0.78 mM vanadate, 
respectively. The inhibition of both the initial rate and total acidification is noncompetitive with respect to ATP. The inhibition is 
abolished when ADP is removed by an ATP-regenerating system, and the addition of exogenous ADP increases the vanadate inhibition of 
proton transport in a synergistic manner, thus demonstrating that inhibition by vanadate is dependent on the presence of ADP and 
explaining the lower effect of vanadate on the initial rate of acidification. Phosphate protects proton transport activity from inhibition by 
vanadate. These effects of ADP and phosphate suggest that inhibition by vanadate may involve the formation of a complex with ADP at a 
nucleotide binding site, possibly at the catalytic site of the enzyme. 
Keywords: Vanadate; Acidification; Vacuolar H’-ATPase; ATPase, H+-, vacuolar; Proton transport; (Kidney) 
1. Introduction 
Active transport of protons across membranes is carried 
out by three families of H+-ATPases: vacuolar (V-type), 
mitochondrial (F,F,-type), and the gastric H+/K+ (P-type) 
ATPases, which are distinguished by differences in subunit 
composition, catalytic mechanism, and pharmacology. V- 
type ATPases catalyze the acidification of various intra- 
cellular compartments in all eukaryotic cells, including 
Golgi, clathrin-coated vesicles, lysosomes, endosomes and 
chromaffin granules [ 1,2], and are also present in the apical 
plasma membrane of cells that specialize in proton secre- 
tion, such as the epithelial renal intercalated cell [3,4], and 
the osteoclast [5-81. They are distinguished pharmacologi- 
cally from the other types of H+-ATPase by their high 
sensitivity to bafilomycin Al [9] and to N-ethylmaleimide 
(NEM), which interacts with a conserved cysteine in the 
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ATP-binding domain of the A subunit of V-type ATPases 
that is absent in the F-type ATPases, making them virtu- 
ally completely resistant to NEM [ 1,101. While the F-type 
ATPases are sensitive to azide and oligomycin, these 
compounds have much lower effects on the V-type AT- 
Pases [ 1,111. The P-type ATPases are poorly inhibited by 
NEM, bafilomycin Al, azide or oligomycin, but are con- 
sidered to be uniquely sensitive to vanadate (IC,, < 10 
/.A41 [1,11,121. 
We and others have, however, found that the V-type 
ATPases present in the osteoclast ruffled-border mem- 
brane, yeast vacuoles and chromaffin granules are sensitive 
to vanadate, with an IC,, of 100-500 PM 18,131, thereby 
raising the possibility that sensitivity to vanadate in the 
high micromolar to millimolar range could be a general 
and as yet unrecognized feature of all V-type ATPases. 
Understanding the mechanism by which vanadate inhibits 
the V-type ATPases can further contribute to our under- 
standing of the catalytic cycle of V-type ATPases. We 
have therefore undertaken to characterize the inhibitory 
effect of vanadate on V-type H+-ATPases. 
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2. Materials and methods 
2.1. Chemicals 
Acridine orange was obtained from Molecular Probes, 
creatine phosphate and creatine kinase were from 
Boehringer Mannheim and sodium orthovanadate 
(Na,VO,), vanadate-free ATP and ADP (potassium salt 
from yeast) were from Sigma. All other materials were 
purchased from Baker. 
Vanadate was freshly prepared on a weekly basis. 
Sodium orthovanadate was dissolved in water and slowly 
titrated to pH 10 with concentrated HCl solution, resulting 
in the appearance of a rusty yellow color which disap- 
peared when the solution was boiled. The cleared solution 
was further boiled for 4 min in order to reduce the content 
of various oxyvanadates. After cooling, the solution was 
brought to its final volume to yield a 200 mM stock 
solution. Prior to any experiment, the vanadate solution 
was kept for 3 h at 37°C to eliminate any decavanadate 
complexes that might have formed [14]. Addition of vana- 
date from the above stock solution to the acidification 
buffer, up to 2 mM final concentration, did not change the 
pH of the solution. 
2.2. Kidney microsomal preparation 
Kidney microsomes were prepared from whole chicken 
kidneys. After removing the capsule, the tissue was minced 
(about 2 g/kidney) and diluted 1:7 (w/v> with cold 
homogenization buffer (20 mM Hepes-KOH, 1 mM EDTA, 
250 mM sucrose (pH 7.4) at 4°C). Homogenization was 
performed on ice by eight strokes of a motor-driven Teflon 
homogenizer at 800 rpm. The homogenate was centrifuged 
for 7 min at 7000 rpm in an SS-34 Beckman rotor at 4°C. 
The pellet was discarded and the supematant was cen- 
trifuged for 40 min at 18000 rpm in the same rotor. The 
supematant was discarded and the pellet contained a dark 
tightly packed center covered with white fluffy mem- 
branes. The fluffy layer, containing the kidney-derived 
microsomes, was recovered by gentle vortexing in the 
presence of 1 ml of buffer A (150 mM KCl, 20 mM 
Hepes-KOH, 2 mM DTT (pH 7.4)) and glycerol was 
added to the suspension to 25% of the final volume. The 
microsomes were aliquoted and stored at -20°C condi- 
tions under which the original proton-transport activity 
was maintained for at least 1 month. Protein determination 
was done by Bradford’s method [15] using the Bio-Rad 
protein assay kit, with bovine serum albumin as a standard. 
2.3. Vesicle acid$cation assay 
The acidification assay is a modification of the one 
described elsewhere [ 161. Unless otherwise specified, 35- 
45 pg of chicken kidney-derived membrane vesicles were 
incubated for 8 min in 2 ml acidification buffer (150 mM 
KCl, 20 mM Hepes-KOH, 5 mM MgCl, (pH 7.4), 5 PM 
acridine orange, 1.25 PM valinomycin) at 25°C. Proton 
transport was initiated by addition of potassium ATP, and 
monitored as the quench of acridine orange fluorescence 
(Ex. 490 nm, Em. 520 nm, with slit width of 10 and 20 
nm, respectively, 400 V using a Hitachi F-2000 fluores- 
cence spectrophotometer). The assay was stopped after 300 
s by addition of 1 PM nigericin. A 10 s interval sampling 
record was generated, from which the initial rate ( AF/min) 
was determined by averaging the change in fluorescence of 
the first 3 or 4 sampling intervals and extrapolated for a 
full minute. Total fluorescence change after addition of 
nigericin ( AF) were also determined from this record. 
2.4. Calculations 
Linear and nonlinear regression analysis were done 
using the program Enzfitter (Elsevier-BIOSOFT). The re- 
sults are given in mean parameter values + standard error. 
3. Results 
3.1. Vanadate inhibits uacuolar H ‘-ATPase-mediatedpro- 
ton transport in kidney microsomes 
For the acidification assay, kidney microsomes (40-50 
pg) were pre-incubated in acidification buffer (i.e., in the 
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Fig. 1. Dose-dependent inhibition of proton transport by vanadate. (A) A 
typical set of assays of control (lower trace) and 750 /.LM vanadate 
(pm-incubated for 8 min) (upper trace) is shown. The acidification assay 
was started by adding 1.5 mM ATP. Vanadate inhibits the initial rate by 
33% and the dF by 51%. (B) Kidney microsomes (50 pg) were 
pre-incubated with increasing concentrations of vanadate (100 /.LM- 10 
mM vanadate) in acidification buffer for 8 min. The acidification assay 
was initiated with 1.5 mM ATP. A dose-dependent inhibition of the 
initial rate of acidification was observed. The continuous line is that using 
the best fit to a model of ligand binding to a single site. Vanadate 
inhibited the initial rate of proton transport with an IC,, = 1.58 + 0.52 
mM vanadate. 
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presence of 5 mM Mg’+) in the presence or absence of 
750 PM vanadate for 8 min. Fig. 1A (bottom trace) 
presents a typical trace obtained in the absence of vana- 
date. The proton transport was initiated by the addition of 
1.5 mM ATP, a concentration that supports maximum 
proton transport activity [17]. The initial rate of proton 
transport, derived from the slope generated by the first 30 s 
of the acidification assay after the addition of ATP, is 
expressed as change of fluorescence units per minute ( AF 
units/min). After a period of 250-300 s, a time at which 
the maximal acidification was usually reached, the system 
was uncoupled by the addition of 1.5 PM nigericin to 
monitor the total fluorescence change achieved due to the 
acidification of the microsomes ( AF). Vanadate reduced 
the initial rate by 33% while decreasing the AF by 51% 
(Fig. lA, upper trace). The inhibition of the initial rate by 
vanadate was dose-dependent, with an IC,, of 1.58 &- 0.52 
mM vanadate (Fig. 1B). Vanadate was consistently found 
to a have a more potent inhibitory effect on the AF with 
an IC,, of 0.78 k 0.11 mM (not shown). 
The inhibition of proton transport by 750 PM vanadate 
was assayed over a range of ATP concentrations (from 
62.5 to 1000 PM). The initial rates (Fig. 2A) and total 
change in fluorescence ( AF) after 300 s (Fig. 2B) were 
measured. Regardless of whether the determination was 
based on the initial rate or on AF, the results are consis- 
tent with a noncompetitive inhibition by vanadate with 
respect to ATP. Both the maximal initial rate and the 
maximal AF were reduced in the presence of vanadate. 
(Maximal initial rate equals 187 f 13 units/min without 
vanadate and 127 + 5 units/min with vanadate; maximal 
AF equals 776 k 73 units without vanadate and 389 + 23 
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Fig. 2. Effect of ATP on vanadate inhibition. Proton transport (45 pg protein) as a function of ATP concentration (62.5-1000 PM ATP) in the absence of 
vanadate (0) or in the presence of 7.50 PM vanadate, 8 min pre-incubation (A ): (A) on the initial rate of proton transport, (B) on the total acidification. 
The continuous lines are the best fit to Michaelis-Menten-type kinetics. The V,,, values of the initial rates were found to be 187 + 13 in control and 
127 f 5 AF units/mm in the presence of vanadate, while the K, values were 13 1 + 30 and 79 + 13 PM ATP, respectively. The maximal acidification of 
the control was found to be 776 & 73 arbitrary units, compared with 389 + 23 arbitrary units in the presence of vanadate; the K, values were 142 + 42 
PM ATP and 111 f 23 /.LM ATP, respectively. The insets represent the Lineweaver-Burk transformations of the data, with the corresponding data points 
with the same symbols, 
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units with vanadate.) The apparent K, for ATP was 
actually higher in the absence of vanadate than in its 
presence (131 + 30 vs. 79 -t 13 PM ATP, respectively, for 
the initial rate and 142 f. 42 vs. 111 f 23 PM ATP, 
respectively, for the AF’), since the percent inhibition by 
vanadate was lower at the lower ATP concentrations. 
3.2. The inhibition of proton transport by uanadate is 
dependent on the presence of ADP 
Our observation that vanadate inhibits the total acidifi- 
cation to a greater extent than the initial rate suggested that 
the accumulation of one or both of the reaction products 
might be potentiating the inhibitory effect of vanadate. We 
first determined whether preventing the accumulation of 
ADP during the acidification assay by including an ATP 
regenerating system would affect the degree of vanadate 
inhibition. Microsomes (50 pg) were pre-incubated in the 
presence and absence of 1 mM vanadate for 8 min, with or 
without 25 units creatine kinase/ml and 20 mM phospho- 
creatine. In the absence of the ATP regenerating system, 
vanadate inhibited the initial rate of proton transport by 
26% and the AF by 45% (Fig. 3A). The presence of the 
ATP regenerating system increased the initial rate of pro- 
ton transport in the vanadate-free assay from 742 to 792 
AF/min, suggesting that the microsomal preparation con- 
tained trace amounts of ADP, and the total acidification 
from 920 to 1029 AF units (compare the lower traces in 
Fig. 3A to Fig. 3B), consistent with the accumulation of 
ADP during the assay when the ATP regenerating system 
is omitted. In the presence of the ATP regenerating sys- 
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Fig. 3. Vanadate has no effect in the presence of an ATP-regenerating 
system. The pre-incubation and acidification assay were performed in the 
absence (A) and the presence (B) of an ATP-regenerating system. The 
acidification assay was initiated with 1.5 mM ATP. (A) Proton transport, 
in the absence of ATE-regenerating system, in the absence (lower trace) 
and presence (upper trace) of 1 mM vanadate (8 min pre-incubation). (B) 
Proton transport, with ATP-regenerating system (25 units/ml creatine 
kinase and 20 mM phosphocreatine) in the absence (lower trace) and 
presence (upper trace) of 1 mM vanadate. 
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Fig. 4. ADP and vanadate interact to inhibit proton transport. Kidney 
microsomes (50 kg protein) were pre-incubated for 8 min with either no 
additions (W), in the presence of 150 PM ADP (01, in the presence of 
750 PM vanadate (A) or in the presence of 150 FM ADP plus 750 FM 
vanadate (+). For each condition, the dose-response curve for ATP 
(60-1500 PM ATP) was generated. The continuous lines are the best fit 
of the data to Michaelis-Menten type kinetics. The V,,, values were 
495 +92 dF/min for control, 52Oi 25 AF/min in the presence of 
ADP, 385+ 13 AF/min in the presence of vanadate and 303 +32 
AF/min in the presence of ADP and vanadate, and the K, values were 
57 + 6 PM ATP for control, 404 i 5 I PM ATP in the presence of ADP, 
61+ 10 PM ATP in the presence of vanadate and 24Ok 81 PM ATP in 
the presence of ADP and vanadate. 
tern, vanadate did not inhibit the initial rate, and the 
inhibition of total acidification was markedly reduced, 
from 45% to 8% (Fig. 3B1, demonstrating that the in- 
hibitory effect of vanadate indeed depends on the accumu- 
lation of ADP in the assay. In addition, this experiment 
excludes the possibility that the presence of ATP and 
Mg2+ are sufficient for the vanadate inhibition to occur, 
and thus demonstrates that the inhibition of V-type 
ATPases and P-type ATPases by vanadate must proceed 
by different mechanisms, since the presence of Mg2+ 
alone is sufficient for vanadate inhibition of the P-type 
ATPases [ 181. 
To further evaluate the role of ADP in the vanadate 
inhibition, we tested the effect of including 150 /.LM ADP 
in the pre-incubation medium, either alone or together with 
vanadate (750 PM) and for the same amount of time (8 
min). An ATP dose-response curve was generated for 
each of the treatments and fitted to a Michaelis-Menten 
kinetic model. The fitted curves of the initial rate values 
are presented in Fig. 4. As we have shown before [ 171, 
ADP alone competitively inhibited proton transport, in- 
creasing the apparent K, for ATP (from 57 + 6 to 404 + 
51 FM ATP) without affecting the V,,, (520 f 25 and 
495 k 92 AF/min, respectively). In contrast, the effect of 
ADP was more complex in the presence of vanadate, with 
characteristics of both competitive and noncompetitive in- 
hibitors. Thus, the apparent K, for ATP increased from 
61 * 10 PM ATP when only vanadate was present to 
240 k 81 PM ATP when both vanadate and ADP were 
present, an effect characteristic of a competitive inhibitor. 
However, the V,,, obtained when ADP was included with 
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Fig. 5. Phosphate protects against vanadate inhibition. Kidney micro- 
somes (50 pg protein) were pm-incubated for 8.5 min in the absence or 
presence of 1.5 mM vanadate and/or 12.5 mM phosphate. The average 
initial rate and standard error of quadruplicate determinations are pre- 
sented. The average initial rates were 690&37 dF/min for control, 
211+31 dF/min in the presence of vanadate alone, 392+24 dF/min 
in the presence of phosphate alone and 400 k 38 dF/min in the presence 
of phosphate and vanadate together. 
vanadate (303 &- 32 AF/min) was lower than the V,,, 
with vanadate alone (385 f 13 AF/min), despite the fact 
that the maximum ATP concentration was 1.5 mM, a 
concentration where ADP alone has little inhibitory effect. 
These results indicate that ADP and vanadate interact, 
since in the absence of such interaction we would have 
expected a competitive-type curve for vanadate plus ADP, 
converging with the curve obtained with vanadate alone. 
3.3. Phosphate protects the enzyme from vanadate inhibi- 
tion 
Phosphate, the other product of ATP hydrolysis, is a 
noncompetitive inhibitor with respect to ATP (K, = 10 
mM) [17]. The effect of phosphate on vanadate inhibition 
was assessed by including 12.5 mM phosphate during the 
8.5 min pre-incubation period in the presence and absence 
of 1.5 mM vanadate (Fig. 5). Vanadate alone reduced the 
initial rate of proton transport from 690 * 37 AF/min to 
211 + 31 AF/min, an inhibition of 70%, while 40 mM 
phosphate alone reduced the initial rate to 392 f 24 
AF/min, an inhibition of 43%. In vesicles pre-incubated 
with 1.5 mM vanadate in the presence of 12.5 mM phos- 
phate, the initial rate of proton transport was 400 -t 38 
AF/min (42% inhibition), a value which is essentially 
identical to the inhibition achieved by phosphate alone. 
Thus, phosphate appears to protect the enzyme against 
vanadate inhibition. 
4. Discussion 
Although sensitivity to vanadate in the low micromolar 
range is a characteristic of P-type ATPases, we and others 
have reported that V-type ATPases from chicken osteo- 
clasts, yeast vacuoles and chromaffin granules are inhib- 
ited by vanadate, with IC,, values ranging from approxi- 
mately 100-500 PM [8,13]. Taken together, these results 
suggest that all V-type ATPases may be susceptible to 
inhibition by vanadate, albeit at significantly higher vana- 
date concentrations than those that inhibit P-type ATPases. 
In the present report, we have demonstrated that the 
chicken kidney V-type ATPase, which was not previously 
studied, is also sensitive to vanadate, and used this system 
to characterize the mechanism of this inhibition. Proton 
transport into chicken kidney microsomes was inhibited by 
vanadate in a dose-dependent manner when saturating 
amounts of ATP were used in the assay. The increase in 
the inhibitory effect of vanadate as the acidification assay 
progressed suggested the possibility that the presence of 
ADP, produced by the V-type ATPase during the assay, 
favored the action of vanadate. In fact, ADP appears to be 
required for vanadate inhibition, as demonstrated by the 
fact that including an ATP regenerating system during the 
preincubation and assay abolished the vanadate-induced 
inhibition of the initial rate of acidification and markedly 
reduced the inhibition seen at the end of the assay period. 
Further demonstration that inhibition by vanadate involves 
an interaction with ADP was provided by the experiment 
showing that the V,,, obtained when both vanadate and 
ADP were present in the assay is much less than that seen 
with vanadate alone. If vanadate and ADP were acting 
independently to inhibit the ATPase, one would expect that 
the presence of ADP would not affect the V,,, , since ADP 
is a competitive inhibitor of ATP, and thus it does not 
inhibit proton transport at high ATP concentrations [ 171. 
The requirement for ADP explains the relationship of 
vanadate inhibition to ATP concentration. As more ATP is 
added to the assay system, more ADP is generated as the 
acidification assay proceeds. Thus, the ADP concentration 
at the time at which AF is measured is significantly higher 
than at the beginning of the experiment, and the increase in 
ADP concentration during the assay is greater at higher 
ATP concentrations, explaining why the effects of vana- 
date on total acidification are more pronounced than the 
effects on the initial rate where only residual or low ADP 
concentrations are present. 
We previously reported that phosphate inhibits the ini- 
tial rate of proton transport in kidney microsomes in a 
noncompetitive manner, with a K, of 10 mM [17]. How- 
ever, inclusion of phosphate with vanadate resulted in a 
degree of inhibition comparable to that induced by phos- 
phate alone and less than that induced by vanadate. This 
antagonism by phosphate and the requirement for ADP 
together suggest that vanadate interacts with the phosphate 
binding region of a nucleotide binding site, possibly the 
catalytic site itself. This hypothesis is supported by our 
observation that omitting Mg*+ from the preincubation 
reduces vanadate’s inhibition of the initial rate of acidifica- 
tion by about half (data not shown), which implies that 
Mg 2f is acting as a cofactor for the binding of the residual 
ADP in the vesicle preparations. If ADP, Mg2+ and 
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vanadate indeed interact at a common site on the V-type 
ATPase, they may form a transition state-like complex that 
mimics the transition state of the catalytic cycle of the 
V-type ATPases, Mg *ADP * Pi, although we cannot rule 
out other possible mechanisms at this time. While the 
transition state of the catalytic cycle seems to be short-lived 
and phosphate is rapidly released [ 171, the transition state- 
like structure that we suggest is formed in the presence of 
vanadate (Mg *ADP * VO,) is apparently more stable, lead- 
ing to inhibition of the catalytic cycle of the V-type 
ATPase. In any case, our results in the present study 
clearly demonstrate that the mechanism of inhibition of 
V-type ATPases by vanadate is distinctly different from 
that described for P-type ATPases. Specifically, inhibition 
of P-type enzymes does not require ADP, and the presence 
of Mg*+ is both necessary and sufficient for vanadate 
inhibition [ 181, whereas our experiment with the ATP-re- 
generating system demonstrates that ADP is required and 
that Mg *’ is not sufficient to support vanadate inhibition 
of V-type enzymes. 
It has recently been reported that vanadate (up to 5 
mM) could not inhibit the activity of purified V-type 
ATPase from chicken osteoclast preparations [19], an ob- 
servation that disagrees with some previous reports [8,13] 
and with our current observations. Since all the reports 
demonstrating vanadate inhibition of V-type ATPase activ- 
ity were based on a proton transport assay using crude 
microsomal preparations, this discrepancy could lead to the 
conclusion that the inhibition of V-type ATPase-mediated 
proton transport by vanadate is indirect, that is, there may 
be another protein in the preparation that regulates the 
pump activity and is sensitive to vanadate in an ADP-de- 
pendent manner. However, there are two differences in the 
experimental conditions used with the two systems that 
could explain the failure to observe inhibition of the 
purified ATPase by vanadate. First, we omit dithiothreitol 
from our acidification assays, since we have found that it 
markedly reduces the inhibitory effect of vanadate on 
proton transport by osteoclast-derived vesicles and, to a 
lesser extent, by kidney vesicles. The presence of dithio- 
threitol in the assays of the purified ATPase could there- 
fore account in part for the failure to detect inhibition by 
vanadate. Second, as we report here, the inhibition by 
vanadate is entirely dependent on the presence of ADP. 
Crude preparations of microsomes likely contain contami- 
nating ATPases and phosphatases that will produce, in a 
time-dependent manner, high enough concentrations of 
ADP to support the inhibition of proton transport by 
vanadate. Purified ATPase preparations, on the other hand, 
have significantly lower total ATPase activity [ 191, and are 
unlikely, therefore, to produce amounts of ADP that are 
sufficient to support the inhibition of proton transport by 
vanadate. Further studies will be required to determine 
which of these explanations is correct, and, more impor- 
tantly, to demonstrate whether or not V-type ATPases 
from a variety of sources are generally susceptible to 
ADP-dependent inhibition by vanadate. 
In conclusion, the V-type ATPase from chicken kidney 
is inhibited by millimolar concentrations of vanadate, as 
has been previously reported for V-type ATPases from 
osteoclasts, yeast and chromaffin granules. Furthermore, 
the inhibition of the kidney ATPase by vanadate requires 
the presence of ADP and Mg’+ and is antagonized by 
phosphate, suggesting that ADP, Mg*+ and vanadate may 
interact at a nucleotide binding site, possibly the catalytic 
site, and may form a transition state-like complex that is 
responsible for the inhibition. 
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